0001235802-19-000105.txt : 20190816
0001235802-19-000105.hdr.sgml : 20190816
20190816163122
ACCESSION NUMBER: 0001235802-19-000105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190816
FILED AS OF DATE: 20190816
DATE AS OF CHANGE: 20190816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pauls Dietrich John
CENTRAL INDEX KEY: 0001760123
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36291
FILM NUMBER: 191033835
MAIL ADDRESS:
STREET 1: 2 CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc.
CENTRAL INDEX KEY: 0001401040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
BUSINESS PHONE: (763) 496-5454
MAIL ADDRESS:
STREET 1: 2 CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
FORMER COMPANY:
FORMER CONFORMED NAME: DiaMedica Inc.
DATE OF NAME CHANGE: 20070525
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-08-16
0
0001401040
DiaMedica Therapeutics Inc.
DMAC
0001760123
Pauls Dietrich John
2 CARLSON PARKWAY
SUITE 260
MINNEAPOLIS
MN
55447
1
1
0
0
President and CEO
Voting Common Shares, no par value per share
2019-08-16
4
P
0
1000
2.6769
A
30804
D
Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
/s/ Amy Culbert, attorney-in-fact
2019-08-16